GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 915 filers reported holding GLAXOSMITHKLINE PLC in Q1 2022. The put-call ratio across all filers is 0.61 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $4,287,000 | -48.3% | 145,663 | -23.5% | 0.19% | -44.2% |
| Q2 2022 | $8,289,000 | -3.3% | 190,421 | -3.3% | 0.34% | +22.4% |
| Q1 2022 | $8,573,000 | -2.7% | 196,819 | -1.4% | 0.28% | -0.7% |
| Q4 2021 | $8,807,000 | +24.1% | 199,698 | +7.5% | 0.28% | +17.7% |
| Q3 2021 | $7,096,000 | -5.7% | 185,716 | -1.7% | 0.24% | +12.3% |
| Q2 2021 | $7,523,000 | +9.4% | 188,915 | -2.0% | 0.21% | +5.5% |
| Q1 2021 | $6,877,000 | +22.3% | 192,699 | +26.1% | 0.20% | +14.3% |
| Q4 2020 | $5,623,000 | -6.4% | 152,805 | -4.3% | 0.18% | -24.9% |
| Q3 2020 | $6,009,000 | -5.3% | 159,639 | +2.6% | 0.23% | -7.9% |
| Q2 2020 | $6,344,000 | +1.7% | 155,520 | -5.5% | 0.25% | -12.5% |
| Q1 2020 | $6,238,000 | -22.4% | 164,631 | -3.7% | 0.29% | -0.3% |
| Q4 2019 | $8,036,000 | +8.4% | 171,009 | -1.6% | 0.29% | +10.7% |
| Q3 2019 | $7,414,000 | +2.8% | 173,709 | -3.6% | 0.26% | +2.7% |
| Q2 2019 | $7,209,000 | -8.5% | 180,147 | -4.4% | 0.26% | -1.9% |
| Q1 2019 | $7,876,000 | +8.9% | 188,459 | -0.4% | 0.26% | +1.6% |
| Q4 2018 | $7,232,000 | -6.9% | 189,261 | -2.1% | 0.26% | +9.4% |
| Q3 2018 | $7,766,000 | -0.7% | 193,319 | -0.4% | 0.23% | -3.7% |
| Q2 2018 | $7,820,000 | +3.1% | 194,005 | -0.0% | 0.24% | +4.7% |
| Q1 2018 | $7,583,000 | +8.4% | 194,093 | -1.6% | 0.23% | +20.8% |
| Q4 2017 | $6,997,000 | +57.8% | 197,274 | +80.7% | 0.19% | +58.7% |
| Q3 2017 | $4,433,000 | -6.2% | 109,194 | -0.4% | 0.12% | -13.6% |
| Q2 2017 | $4,725,000 | +1.4% | 109,584 | -0.9% | 0.14% | +4.5% |
| Q1 2017 | $4,662,000 | +5.8% | 110,579 | -3.4% | 0.13% | -2.9% |
| Q4 2016 | $4,407,000 | -11.0% | 114,437 | -0.4% | 0.14% | -7.4% |
| Q3 2016 | $4,953,000 | -1.9% | 114,844 | -1.4% | 0.15% | +4.9% |
| Q2 2016 | $5,049,000 | +7.3% | 116,491 | +0.4% | 0.14% | +9.2% |
| Q1 2016 | $4,707,000 | -12.4% | 116,070 | -12.8% | 0.13% | -17.7% |
| Q4 2015 | $5,372,000 | +4.7% | 133,124 | -0.3% | 0.16% | +3.3% |
| Q3 2015 | $5,131,000 | -4.0% | 133,458 | +4.0% | 0.15% | +3.4% |
| Q2 2015 | $5,343,000 | -11.9% | 128,285 | -2.3% | 0.15% | -9.8% |
| Q1 2015 | $6,062,000 | +5.6% | 131,346 | -2.2% | 0.16% | +11.6% |
| Q4 2014 | $5,740,000 | -11.0% | 134,293 | -4.3% | 0.15% | -0.7% |
| Q3 2014 | $6,449,000 | -15.1% | 140,278 | -1.3% | 0.15% | -8.6% |
| Q2 2014 | $7,600,000 | -0.2% | 142,118 | -0.3% | 0.16% | -7.4% |
| Q1 2014 | $7,619,000 | -5.0% | 142,598 | -5.1% | 0.18% | -5.9% |
| Q4 2013 | $8,018,000 | +5.8% | 150,184 | -0.6% | 0.19% | +2.2% |
| Q3 2013 | $7,577,000 | +0.4% | 151,030 | -0.0% | 0.18% | -3.7% |
| Q2 2013 | $7,550,000 | – | 151,090 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |